Swedish Banks Stock News

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

Camurus AB (publ) recently announced that the U.S. FDA has accepted for review its resubmitted New Drug Application for Oclaiz (CAM2029), an extended-release octreotide injection for acromegaly, with a PDUFA target action date set for 10 June 2026. This acceptance helps clear a prior hurdle tied to third-party manufacturing observations and follows earlier EU and UK approvals and launch of the same product, marketed there as Oczyesa. We will now examine how FDA acceptance of the Oclaiz...

When close to half the companies in Sweden have price-to-earnings ratios (or "P/E's") below 22x, you may consider Sweco...

Investment AB Latour (publ) ( STO:LATO B ) saw significant share price movement during recent months on the OM, rising...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Why Nobia’s rights issue and UK exit matter for shareholders Nobia (OM:NOBI) is overhauling its business by selling its UK operations, refocusing on Nordic markets, and raising approximately SEK 1.5b through a rights issue, together with new loan agreements and planned capital structure changes. See our latest analysis for Nobia. The rights issue, UK exit and refinancing have come against a weak share price backdrop, with a 7 day share price return of 27.12% decline and a 5 year total...

Bonesupport Holding (OM:BONEX) shares are back in focus after the company issued preliminary fourth quarter 2025 figures, indicating 36% net sales growth to 313 MSEK and providing guidance for sales growth above 35% for 2026. See our latest analysis for Bonesupport Holding. The preliminary Q4 2025 update came after a mixed share price run, with a 7 day share price return of 14.18% and a 30 day gain of 18.21% contrasting with a 90 day share price decline of 17.90% and a 1 year total...

Recent share price performance and business profile Swedish Orphan Biovitrum (OM:SOBI) has seen mixed share price moves recently, with a 2.5% decline over the past day and a 4.7% decline over the past week, but a modest gain over the past month. Over longer periods, the stock shows a small 1 year total return near flat. The past 3 years and past 5 years reflect much stronger total returns compared with shorter term performance. The company focuses on haematology, immunology, and specialty...

Truecaller (OM:TRUE B) has completed another round of share repurchases, taking treasury holdings to 5.02%, with the buyback programme timed ahead of the company’s 2026 Annual General Meeting. See our latest analysis for Truecaller. Despite the latest buybacks, the share price has come under pressure, with a 1 day share price return of a 2.96% decline, a 7 day share price return of a 9.94% decline and a 90 day share price return of a 57.88% decline. The 1 year total shareholder return of a...

Why Betsson’s latest guidance has grabbed investor attention Betsson (OM:BETS B) has come under pressure after preliminary Q4 2025 guidance pointed to softer results, with revenue expected at €304 million and operating income at €53 million, both below the prior year. The update, combined with weaker sportsbook and B2B trends, triggered a sharp share price reaction. This has left many investors reassessing how the business mix, regional performance, and ongoing product investments could shape...

Telefonaktiebolaget LM Ericsson (OM:ERIC B) has drawn fresh investor attention after announcing proposed staff reductions affecting about 1,600 positions in Sweden, as part of wider cost focused initiatives across the group. See our latest analysis for Telefonaktiebolaget LM Ericsson. At a share price of SEK 87.52, Ericsson has seen a 1-year total shareholder return decline of 4.82%, although the 3-year total shareholder return of 68.28% suggests longer term momentum has been stronger than...

Despite an already strong run, Ferroamp AB (publ) ( STO:FERRO ) shares have been powering on, with a gain of 26% in the...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

When close to half the companies in Sweden have price-to-earnings ratios (or "P/E's") below 22x, you may consider ASSA...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Investors who take an interest in Case Group AB (publ) ( STO:CASE ) should definitely note that the Independent...

Betsson AB (publ) ( STO:BETS B ) shareholders that were waiting for something to happen have been dealt a blow with a...

With a price-to-earnings (or "P/E") ratio of 19.2x Holmen AB (publ) ( STO:HOLM B ) may be sending bullish signals at...

Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend of SEK1.20 per share on the 11th of March...

Nobia AB (publ) has announced plans for a SEK 1.50 billion rights issue alongside an amended and extended SEK 2.50 billion revolving credit facility and a SEK 1.50 billion bridge term facility, supported by proposed changes to its articles of association to allow share capital reduction without redeeming shares. Together, these financing and governance measures point to a significant balance sheet reshaping that could influence Nobia’s financial flexibility and future capital structure...

As the European markets continue to show optimism with indices like the STOXX Europe 600 Index ending higher amid a strengthening eurozone economy, investors are increasingly drawn to dividend stocks as a means of enhancing portfolio stability. In this context, selecting stocks that offer reliable dividends can be particularly appealing, providing both income and potential growth in an environment characterized by favorable interest rates and improving industrial production.

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

MilDef Group AB (publ) ( STO:MILDEF ), is not the largest company out there, but it led the OM gainers with a...